c15-162: Phase IB trial of radium 223 and niraparib in patients with castrate resistant prostate cancer (NiraRad).

被引：0
|
作者：
Godwin, James Luke
Hoffman-Censits, Jean H.
Den, Robert Benjamin
Knudsen, Karen E.
Schiewer, Matthew Joseph
Leiby, Benjamin E.
Southwell, Traci
Hubert, Christine
Patnaik, Akash
Sonpavde, Guru
Sartor, A. Oliver
Yang, Eddy Shih-Hsin
Kelly, William Kevin
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
[3] Jefferson Med Coll Thomas Jefferson Univ, Philadelphia, PA USA
[4] Thomas Jefferson Univ, Philadelphia, PA USA
[5] Beth Israel Deaconess Med Ctr Dana Farber Canc In, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MD USA
[7] Tulane Univ Sch Med, New Orleans, LA USA
[8] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.TPS385
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS385
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Biomarker analysis of phase (Ph) IB trial of radium-223 (Rad) and niraparib (Nira) in patients (Pts) with metastatic castrate-resistant prostate cancer (mCRPC) (NiraRad).
    Yang, Eddy Shih-Hsin
    Leiby, Benjamin
    Sonpavde, Guru P.
    Einstein, David Johnson
    Quinn, Zachary L.
    Szmulewitz, Russell Zelig
    Sartor, A. Oliver
    Kelly, William Kevin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
    Quinn, Zachary
    Leiby, Benjamin
    Sonpavde, Guru
    Choudhury, Atish D.
    Sweeney, Christopher
    Einstein, David
    Szmulewitz, Russell
    Sartor, Oliver
    Knudsen, Karen
    Yang, Eddy Shih-Hsin
    Kelly, Wm. Kevin
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (01) : 50 - 59
  • [3] A phase Ib trial to study the safety and tolerability of atezolizumab with radium-223 dichloride in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Fong, Lawrence
    Morris, Michael
    Armstrong, Andrew
    Petrylak, Daniel
    Vaishampayan, Ulka
    Alva, Ajjai
    Hoffman-Censits, Jean
    Sarkar, Indrani
    Carroll, Susheela
    Schiff, Christina
    Sartor, Oliver
    [J]. CANCER RESEARCH, 2017, 77
  • [4] Radium-223 for Metastatic Castrate-Resistant Prostate Cancer
    Sindhu, Kunal K.
    Nehlsen, Anthony D.
    Stock, Richard G.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2022, 12 (04) : 312 - 316
  • [5] Completion of radium-223 dichloride treatment regimen for patients with castrate resistant prostate cancer
    Amin, Kanak
    Shrikanthan, Sankaran
    Richard, Full
    Neumann, Donald
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [6] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [7] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [8] Radium-223 (Rad) and niraparib (Nira) treatment (tx) in castrate-resistant prostate cancer (CRPC) patients (pts) with and without prior chemotherapy (chemo).
    Kelly, William Kevin
    Leiby, Benjamin
    Einstein, David Johnson
    Szmulewitz, Russell Zelig
    Sartor, A. Oliver
    Yang, Eddy Shih-Hsin
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
    Modi, Dipenkumar
    Hwang, Clara
    Mamdani, Hirva
    Kim, Seongho
    Gayar, Hesham
    Vaishampayan, Ulka
    Joyrich, Richard
    Heath, Elisabeth I.
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 373 - 380
  • [10] Early Real Life Experience of Radium 223 (Ra223) in Castrate Resistant Prostate Cancer (CRPC)
    Hague, C.
    Fisher, C.
    O'Hara, C.
    Elliott, P.
    Wylie, J.
    Choudhury, A.
    Tran, A.
    Coyle, C.
    Livsey, J.
    Logue, J.
    [J]. CLINICAL ONCOLOGY, 2016, 28 (05) : E9 - E9
12345